Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pollastri

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|May 23, 2022
Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug DevelopmentCarlos E Sanz-Rodríguez, Benjamin Hoffman, Paul J Guyett, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 1. Sildenafil analogsCuihua Wang, Trent D Ashton, Alden Gustafson, et al.
Medchemcomm|June 10, 2014
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discoveryGautam Patel, Norma E Roncal, Patricia J Lee, et al.
ACS Medicinal Chemistry Letters|September 17, 2025
Optimization of Quinazolines for Inhibition of <i>Trypanosoma brucei</i> ProliferationSam Spijkers-Shaw, Pradip K Gadekar, Baljinder Singh, et al.
Plos Neglected Tropical Diseases|September 5, 2014
A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodesBrendan D Galvin, Zhiru Li, Estelle Villemaine, et al.
Journal of Medicinal Chemistry|April 20, 2013
Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasisGautam Patel, Caitlin E Karver, Ranjan Behera, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|December 23, 2016
Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essayA Di Legge, P Pollastri, R Mancari, et al.
Medchemcomm|February 17, 2015
EVALUATION OF AROMATIC 6-SUBSTITUTED THIENOPYRIMIDINES AS SCAFFOLDS AGAINST PARASITES THAT CAUSE TRYPANOSOMIASIS, LEISHMANIASIS, AND MALARIAJennifer L Woodring, Gautam Patel, Jessey Erath, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan ParasitesWilliam Devine, Sarah M Thomas, Jessey Erath, et al.
Journal of Medicinal Chemistry|August 14, 2020
Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for <i>Trypanosoma brucei</i> InhibitorsBaljinder Singh, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|May 23, 2022
Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug DevelopmentCarlos E Sanz-Rodríguez, Benjamin Hoffman, Paul J Guyett, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 1. Sildenafil analogsCuihua Wang, Trent D Ashton, Alden Gustafson, et al.
Medchemcomm|June 10, 2014
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discoveryGautam Patel, Norma E Roncal, Patricia J Lee, et al.
ACS Medicinal Chemistry Letters|September 17, 2025
Optimization of Quinazolines for Inhibition of <i>Trypanosoma brucei</i> ProliferationSam Spijkers-Shaw, Pradip K Gadekar, Baljinder Singh, et al.
Plos Neglected Tropical Diseases|September 5, 2014
A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodesBrendan D Galvin, Zhiru Li, Estelle Villemaine, et al.
Journal of Medicinal Chemistry|April 20, 2013
Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasisGautam Patel, Caitlin E Karver, Ranjan Behera, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|December 23, 2016
Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essayA Di Legge, P Pollastri, R Mancari, et al.
Medchemcomm|February 17, 2015
EVALUATION OF AROMATIC 6-SUBSTITUTED THIENOPYRIMIDINES AS SCAFFOLDS AGAINST PARASITES THAT CAUSE TRYPANOSOMIASIS, LEISHMANIASIS, AND MALARIAJennifer L Woodring, Gautam Patel, Jessey Erath, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan ParasitesWilliam Devine, Sarah M Thomas, Jessey Erath, et al.
Journal of Medicinal Chemistry|August 14, 2020
Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for <i>Trypanosoma brucei</i> InhibitorsBaljinder Singh, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Pageof 8